These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 33713067)

  • 21. Isoagglutinin adsorption in ABO-incompatible transplantation.
    Genberg H; Kumlien G; Wennberg L; Tydén G
    Transfus Apher Sci; 2010 Oct; 43(2):231-5. PubMed ID: 20667787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strategic breakthrough in adult ABO-incompatible living donor liver transplantation: preliminary results of consecutive seven cases.
    Soejima Y; Muto J; Matono R; Ninomiya M; Ikeda T; Yoshizumi T; Uchiyama H; Ikegami T; Shirabe K; Maehara Y
    Clin Transplant; 2013; 27(2):227-31. PubMed ID: 23293980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of desensitization methods: Rituximab with/without plasmapheresis in ABO-incompatible living donor liver transplantation.
    Lee EC; Kim SH; Shim JR; Park SJ
    Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):119-125. PubMed ID: 29576278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ABO-incompatible kidney transplantation using both A2 and non-A2 living donors.
    Gloor JM; Lager DJ; Moore SB; Pineda AA; Fidler ME; Larson TS; Grande JP; Schwab TR; Griffin MD; Prieto M; Nyberg SL; Velosa JA; Textor SC; Platt JL; Stegall MD
    Transplantation; 2003 Apr; 75(7):971-7. PubMed ID: 12698082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ABO-incompatible deceased donor pediatric liver transplantation: Novel titer-based management protocol and outcomes.
    Mysore KR; Himes RW; Rana A; Teruya J; Desai MS; Srivaths PR; Zaruca K; Calvert A; Guffey D; Minard CG; Morita E; Hensch L; Losos M; Kostousov V; Hui SR; Orange JS; Goss JA; Nicholas SK
    Pediatr Transplant; 2018 Nov; 22(7):e13263. PubMed ID: 30070010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ABO-Incompatible Living Donor Liver Transplantation with Reduced Rituximab Dose: A Retrospective Analysis of 65 Patients - Can We Fast-Track Liver Transplant Surgery and Improve Long-Term Survival?
    Hsu SC; Thorat A; Jeng LB; Li PC; Chen TH; Yang HR; Poon KS
    Ann Transplant; 2020 Sep; 25():e923502. PubMed ID: 32943600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome of ABO-Incompatible Living Donor Renal Transplantations: A Single-Center Experience From Eastern India.
    Ray DS; Thukral S
    Transplant Proc; 2016 Oct; 48(8):2622-2628. PubMed ID: 27788792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic strategy and the role of apheresis therapy for ABO incompatible living donor liver transplantation.
    Kozaki K; Egawa H; Kasahara M; Oike F; Yoshizawa A; Fukatsu A; Tanaka K
    Ther Apher Dial; 2005 Aug; 9(4):285-91. PubMed ID: 16076368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of plasmapheresis therapy for perioperative management in ABO-incompatible adult living donor liver transplantation.
    Ashizawa T; Matsuno N; Yokoyama T; Kihara Y; Kuzuoka K; Taira S; Konno O; Jyojima Y; Akashi I; Nakamura Y; Hama K; Iwamoto H; Iwahori T; Nagao T; Kasahara M; Tanaka K
    Transplant Proc; 2006 Dec; 38(10):3629-32. PubMed ID: 17175351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of 2 Doses of Rituximab on B-Cell and Antidonor Antibody and Outcomes of ABO-Incompatible Living-Donor Pediatric Kidney Transplant.
    Hamasaki Y; Aikawa A; Itabashi Y; Muramatsu M; Hyoudou Y; Shinoda K; Takahashi Y; Sakurabayashi K; Mizutani T; Oguchi H; Kawamura T; Sakai K; Shishido S
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):105-109. PubMed ID: 30777532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Excellent outcome following emergency deceased donor ABO-incompatible liver transplantation using rituximab and antigen specific immunoadsorption.
    Skogsberg Dahlgren U; Herlenius G; Gustafsson B; Mölne J; Rydberg L; Socratous A; Bennet W
    Scand J Gastroenterol; 2022 Jan; 57(1):50-59. PubMed ID: 34541993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ABO-incompatible adult living donor liver transplantation for hepatocellular carcinoma.
    Matsuno N; Iwamoto H; Nakamura Y; Hama K; Kihara Y; Konno O; Jojima Y; Akashi I; Mijiti A; Ashizawa T; Nagao T
    Transplant Proc; 2008 Oct; 40(8):2497-500. PubMed ID: 18929778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma exchange conditioning for ABO-incompatible renal transplantation.
    Winters JL; Gloor JM; Pineda AA; Stegall MD; Moore SB
    J Clin Apher; 2004; 19(2):79-85. PubMed ID: 15274200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved graft survival in ABO-incompatible living donor kidney transplantation.
    Kaihara S; Okamoto M; Akioka K; Ogino S; Higuchi A; Kadotani Y; Nobori S; Yoshimura N
    Transplant Proc; 2005 May; 37(4):1804-5. PubMed ID: 15919472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initial experience with ABO-incompatible live donor renal transplantation.
    Tsai MK; Wu MH; Lo SC; Lai IR; Yu SC; Yuan RH; Lee PH
    J Formos Med Assoc; 2006 Sep; 105(9):775-9. PubMed ID: 16959628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A simplified protocol using rituximab and immunoglobulin for ABO-incompatible low-titre living donor liver transplantation.
    Kim SH; Lee EC; Shim JR; Park SJ
    Liver Int; 2018 May; 38(5):932-939. PubMed ID: 29053910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ABO-incompatible deceased donor liver transplantation with the use of antigen-specific immunoadsorption and anti-CD20 monoclonal antibody.
    Boberg KM; Foss A; Midtvedt K; Schrumpf E
    Clin Transplant; 2006; 20(2):265-8. PubMed ID: 16640538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of the prevalence of systemic de novo thrombotic microangiopathy after ABO-incompatible kidney transplantation and the associated risk factors.
    Tasaki M; Saito K; Nakagawa Y; Imai N; Ito Y; Yoshida Y; Ikeda M; Ishikawa S; Narita I; Takahashi K; Tomita Y
    Int J Urol; 2019 Dec; 26(12):1128-1137. PubMed ID: 31587389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful use of anti-CD20 monoclonal antibody (rituximab) for ABO-incompatible living-related liver transplantation.
    Usuda M; Fujimori K; Koyamada N; Fukumori T; Sekiguchi S; Kawagishi N; Akamatsu Y; Enomoto Y; Satoh K; Satoh A; Ishida K; Moriya T; Satomi S
    Transplantation; 2005 Jan; 79(1):12-6. PubMed ID: 15714163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ABO incompatible living donor kidney transplantation in Korea: highly uniform protocols and good medium-term outcome.
    Kong JM; Ahn J; Park JB; Chung BH; Yang J; Kim JK; Huh KH; Kim JM
    Clin Transplant; 2013; 27(6):875-81. PubMed ID: 24118271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.